Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Methodological standard · §5

CEI-MS-07 — system suitability and acceptance criteria

The performance the system must demonstrate, and the criteria a result must meet to be reportable.

Document identifier
CEI-MS-07/5
Series
Methodological standard
Version
1.1
Published
24 Oct 2024
Last reviewed
24 Jul 2025
Next review
24 Jul 2028
Identifier
10.71829/cei.meth.7
Certainty
High
Cycle
2024 Q4
Category
Physical quality

§5System suitability and acceptance criteria

§5.1System suitability

Table 1. System suitability criteria. A determination is reportable only where every criterion is met at the time of analysis.

ParameterCriterionWhat it establishes
Particle-standard recoveryWithin stated toleranceCounter calibration
Blank count< 10 % of the acceptance limitDiluent and glassware cleanliness
Aliquots counted≥ 4, first discardedFlush of the sensing zone
Relative standard deviation between aliquots≤ 15 %Homogeneity and absence of bubbles

§5.2Acceptance criteria

  • For small-volume parenterals the limits are 6000 particles ≥ 10 µm and 600 particles ≥ 25 µm per container.
  • A count obtained on an agitated or freshly shaken sample is not reportable.
  • A visibly particulate reconstituted solution fails on inspection and no count is required.

§5.3Limitations

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.